U.S. Pharmaceutical Sales - Q2 2013
The following is a list of the top 100 prescribed medicines by U.S. National Sales in Q2 2013. Figures include sales through both retail and hospital channels, listed by drug name and sales value in U.S. dollars.
Last updated: February 2014 (updated quarterly).
Top 100 drugs for Q2 2013 by sales
Rank |
Drug |
Sales ($000) |
|
|
1 |
Abilify Otsuka Pharmaceutical Co., Ltd |
1,597,913 |
4.70% |
Stats |
2 |
Nexium AstraZeneca |
1,454,048 |
-0.34% |
Stats |
3 ( 3) |
Humira AbbVie Inc. |
1,341,759 |
10.22% |
Stats |
4 ( 1) |
Cymbalta
|
1,338,912 |
3.24% |
Stats |
5 ( 1) |
Crestor AstraZeneca |
1,290,913 |
-0.37% |
Stats |
6 ( 1) |
Advair Diskus GlaxoSmithKline |
1,241,430 |
-2.80% |
Stats |
7 |
Enbrel Amgen Inc. |
1,147,929 |
6.76% |
Stats |
8 |
Remicade Janssen Pharmaceuticals, Inc. |
995,800 |
2.76% |
Stats |
9 |
Copaxone Teva Pharmaceuticals USA, Inc. |
933,319 |
0.79% |
Stats |
10 |
Neulasta Amgen Inc. |
860,860 |
0.21% |
Stats |
11 |
Rituxan Genentech, Inc. |
825,949 |
3.96% |
Stats |
12 |
Spiriva Boehringer Ingelheim Pharmaceuticals, Inc. |
722,993 |
-0.42% |
Stats |
13 |
Atripla Gilead Sciences, Inc. |
714,464 |
-1.24% |
Stats |
14 |
Januvia Merck |
692,528 |
-1.23% |
Stats |
15 ( 2) |
Lantus Solostar Sanofi |
682,489 |
7.11% |
Stats |
16 |
Avastin Genentech, Inc. |
667,885 |
4.22% |
Stats |
17 ( 2) |
OxyContin Purdue Pharma LP |
621,785 |
-4.71% |
Stats |
18 |
Lantus Sanofi |
599,306 |
1.18% |
Stats |
19 |
Lyrica
|
572,526 |
3.53% |
Stats |
20 ( 1) |
Truvada Gilead Sciences, Inc. |
551,873 |
2.78% |
Stats |
21 ( 2) |
Epogen Amgen Inc. |
550,816 |
9.40% |
Stats |
22 |
Celebrex
|
533,077 |
2.85% |
Stats |
23 ( 3) |
Diovan Novartis Pharmaceuticals Corporation |
532,798 |
-0.99% |
Stats |
24 ( 2) |
Gleevec Novartis Pharmaceuticals Corporation |
472,509 |
7.85% |
Stats |
25 |
Namenda
|
469,630 |
4.67% |
Stats |
26 ( 2) |
Herceptin Genentech, Inc. |
467,892 |
-0.74% |
Stats |
27 ( 2) |
Lucentis Genentech, Inc. |
453,064 |
9.07% |
Stats |
28 ( 1) |
Vyvanse Takeda Pharmaceutical Company Limited |
402,189 |
-6.66% |
Stats |
29 ( 2) |
Zetia Merck |
398,591 |
0.89% |
Stats |
30 ( 4) |
Symbicort AstraZeneca |
383,928 |
1.89% |
Stats |
31 ( 7) |
Lidoderm Endo Pharmaceuticals Inc. |
382,635 |
10.71% |
Stats |
32 ( 3) |
OneTouch
|
366,005 |
-0.71% |
Stats |
33 ( 3) |
enoxaparin Generic |
365,164 |
0.02% |
Stats |
34 ( 6) |
Levemir Novo Nordisk |
364,156 |
8.40% |
Stats |
35 ( 2) |
methylphenidate Generic |
352,988 |
-7.92% |
Stats |
36 ( 1) |
AndroGel AbbVie Inc. |
345,297 |
-0.84% |
Stats |
37 ( 9) |
Suboxone
|
337,109 |
-18.95% |
Stats |
38 ( 3) |
Rebif EMD Serono, Inc. |
325,937 |
-1.96% |
Stats |
39 ( 4) |
NovoLog FlexPen Novo Nordisk |
323,641 |
2.10% |
Stats |
40 ( 2) |
Novolog Novo Nordisk |
319,752 |
-0.94% |
Stats |
41 ( 2) |
Avonex Biogen Inc. |
306,073 |
-9.51% |
Stats |
42 ( 7) |
Alimta Eli Lilly and Company |
303,419 |
10.84% |
Stats |
43 ( 1) |
Seroquel XR AstraZeneca |
302,919 |
-0.49% |
Stats |
44 ( 2) |
Nasonex Merck |
291,694 |
2.75% |
Stats |
45 |
Viagra
|
284,912 |
-1.37% |
Stats |
46 ( 43) |
doxycycline Generic |
282,549 |
46.22% |
Stats |
47 ( 9) |
ProAir HFA Teva Pharmaceuticals USA, Inc. |
276,177 |
5.28% |
Stats |
48 |
Humalog Eli Lilly and Company |
275,495 |
-1.26% |
Stats |
49 ( 2) |
Niaspan AbbVie Inc. |
270,850 |
-3.62% |
Stats |
50 ( 2) |
Lovaza GlaxoSmithKline |
263,998 |
-1.47% |
Stats |
51 ( 9) |
Victoza Novo Nordisk |
262,064 |
8.23% |
Stats |
52 ( 15) |
Gilenya Novartis Pharmaceuticals Corporation |
260,801 |
10.75% |
Stats |
53 ( 2) |
amphetamine/dextroamphetamine Generic |
258,342 |
-2.74% |
Stats |
54 ( 1) |
Flovent HFA GlaxoSmithKline |
256,187 |
-3.99% |
Stats |
55 ( 6) |
Procrit Janssen Pharmaceuticals, Inc. |
255,636 |
6.00% |
Stats |
56 ( 1) |
Cialis Eli Lilly and Company |
254,053 |
0.24% |
Stats |
57 ( 2) |
Isentress Merck |
252,347 |
3.58% |
Stats |
58 |
acetaminophen/hydrocodone Generic |
251,449 |
-0.20% |
Stats |
59 ( 6) |
Restasis Allergan plc |
248,265 |
4.54% |
Stats |
60 ( 9) |
Prezista Janssen Pharmaceuticals, Inc. |
246,892 |
9.23% |
Stats |
61 ( 11) |
budesonide Generic |
245,828 |
-9.50% |
Stats |
62 ( 11) |
fenofibrate Generic |
242,545 |
-9.66% |
Stats |
63 ( 3) |
metoprolol Generic |
239,691 |
1.44% |
Stats |
64 ( 10) |
Orencia Bristol-Myers Squibb Company |
237,840 |
9.63% |
Stats |
65 ( 1) |
Reyataz Bristol-Myers Squibb Company |
237,689 |
-0.17% |
Stats |
66 ( 4) |
Janumet Merck |
235,251 |
-1.98% |
Stats |
67 ( 4) |
Neupogen Amgen Inc. |
232,559 |
-3.07% |
Stats |
68 ( 13) |
Stelara Janssen Pharmaceuticals, Inc. |
223,466 |
10.65% |
Stats |
69 ( 1) |
VESIcare Astellas Pharma US, Inc. |
222,831 |
1.16% |
Stats |
70 ( 7) |
Dexilant Takeda Pharmaceutical Company Limited |
221,770 |
5.60% |
Stats |
71 ( ) |
Xarelto
|
215,335 |
n/a |
Stats |
72 ( 1) |
Vytorin Merck |
214,140 |
-2.71% |
Stats |
73 ( 2) |
Pradaxa Boehringer Ingelheim Pharmaceuticals, Inc. |
207,826 |
-3.34% |
Stats |
74 ( 2) |
Renvela Sanofi |
207,762 |
-1.52% |
Stats |
75 ( 7) |
Incivek Vertex Pharmaceuticals Incorporated |
205,010 |
-12.42% |
Stats |
76 ( 3) |
Benicar Daiichi Sankyo |
204,630 |
-0.04% |
Stats |
77 ( 6) |
Synthroid AbbVie Inc. |
204,588 |
1.94% |
Stats |
78 ( 15) |
Xolair
|
203,853 |
11.87% |
Stats |
79 ( 5) |
Evista
|
201,330 |
1.91% |
Stats |
80 |
Aranesp Amgen Inc. |
200,386 |
-1.61% |
Stats |
81 ( 1) |
Humalog KwikPen Eli Lilly and Company |
199,948 |
-0.84% |
Stats |
82 ( 8) |
Lunesta Sunovion Pharmaceuticals Inc. |
198,841 |
5.05% |
Stats |
83 ( 5) |
Aciphex Eisai Inc. |
196,514 |
-6.17% |
Stats |
84 ( ) |
Zytiga Janssen Pharmaceuticals, Inc. |
192,916 |
n/a |
Stats |
85 ( 10) |
Prevnar 13 Pfizer Inc. |
191,499 |
6.00% |
Stats |
86 ( 8) |
Xgeva Amgen Inc. |
189,422 |
3.97% |
Stats |
87 |
Betaseron Bayer HealthCare Pharmaceuticals Inc. |
189,215 |
-3.25% |
Stats |
88 ( 15) |
modafinil Generic |
187,194 |
-14.37% |
Stats |
89 ( 8) |
Xeloda Genentech, Inc. |
186,517 |
6.87% |
Stats |
90 ( ) |
Invega Sustenna Janssen Pharmaceuticals, Inc. |
184,629 |
n/a |
Stats |
91 ( 5) |
Sensipar Amgen Inc. |
184,192 |
2.21% |
Stats |
92 ( 53) |
Avonex Pen Biogen Inc. |
183,376 |
-45.78% |
Stats |
93 ( 7) |
Adderall XR Takeda Pharmaceutical Company Limited |
182,134 |
-7.28% |
Stats |
94 ( 4) |
omeprazole Generic |
180,882 |
4.76% |
Stats |
95 ( 4) |
fentanyl Generic |
180,336 |
-4.71% |
Stats |
96 ( 4) |
Zyvox Pfizer Inc. |
178,348 |
-5.18% |
Stats |
97 ( 12) |
Ventolin HFA GlaxoSmithKline |
174,225 |
-11.76% |
Stats |
98 ( ) |
Sandostatin LAR Depot Novartis Pharmaceuticals Corporation |
173,030 |
n/a |
Stats |
99 ( 11) |
atorvastatin Generic |
172,239 |
-10.88% |
Stats |
100 ( ) |
Afinitor Novartis Pharmaceuticals Corporation |
171,337 |
n/a |
Stats |
* Units refer to the number of packages sold.
Source: IMS Health (Midas). Please review our terms of use and attribution guidelines. Copyright - All rights reserved. Unauthorized use and/or duplication of this material without express written permission is strictly prohibited.